Financial Ratios Canadian Natural Resources Limited
Equities
CNQ
CA1363851017
Oil & Gas Exploration and Production
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.27 CAD | +4.06% |
|
-1.52% | +38.24% |
| 05-11 | Canada research roundup - AG Growth International, Extendicare, TMX Group | RE |
| 05-08 | Canadian Natural Resources Upgraded to Outperform at Raymond James | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.8 | 12.06 | 8.58 | 7.53 | 5.76 | |||||
Return on Total Capital | 10.9 | 17.65 | 12.63 | 10.85 | 8.24 | |||||
Return On Equity % | 22.11 | 29.12 | 21.11 | 15.4 | 25.81 | |||||
Return on Common Equity | 22.11 | 29.12 | 21.11 | 15.4 | 25.81 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 54.23 | 55.83 | 50.56 | 49.3 | 48.46 | |||||
SG&A Margin | 1.22 | 0.98 | 1.26 | 1.41 | 1.59 | |||||
EBITDA Margin % | 50.49 | 52.9 | 45.9 | 45.79 | 40.84 | |||||
EBITA Margin % | 32.17 | 35.52 | 30.04 | 28.35 | 22.03 | |||||
EBIT Margin % | 31.55 | 34.85 | 29.03 | 27.26 | 21.05 | |||||
Income From Continuing Operations Margin % | 25.5 | 25.86 | 22.89 | 17.12 | 27.91 | |||||
Net Income Margin % | 25.5 | 25.86 | 22.89 | 17.12 | 27.91 | |||||
Net Avail. For Common Margin % | 25.5 | 25.86 | 22.89 | 17.12 | 27.91 | |||||
Normalized Net Income Margin | 19.32 | 19.96 | 17.57 | 14.03 | 13.18 | |||||
Levered Free Cash Flow Margin | 30.16 | 30.99 | 16.85 | 18.97 | 16.57 | |||||
Unlevered Free Cash Flow Margin | 31.71 | 31.98 | 18.05 | 20.15 | 18.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.4 | 0.55 | 0.47 | 0.44 | 0.44 | |||||
Fixed Assets Turnover | 0.43 | 0.61 | 0.53 | 0.49 | 0.48 | |||||
Receivables Turnover (Average Receivables) | 11.34 | 12.69 | 10.67 | 9.75 | 9.54 | |||||
Inventory Turnover (Average Inventory) | 10.55 | 11.11 | 9.24 | 7.49 | 7.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.8 | 0.82 | 0.96 | 0.77 | 0.95 | |||||
Quick Ratio | 0.56 | 0.57 | 0.62 | 0.44 | 0.58 | |||||
Operating Cash Flow to Current Liabilities | 1.95 | 2.24 | 1.66 | 1.39 | 1.87 | |||||
Days Sales Outstanding (Average Receivables) | 32.19 | 28.76 | 34.22 | 37.54 | 38.25 | |||||
Days Outstanding Inventory (Average Inventory) | 34.6 | 32.85 | 39.5 | 48.87 | 49.46 | |||||
Average Days Payable Outstanding | 18.83 | 20.65 | 27.97 | 24.26 | 20.13 | |||||
Cash Conversion Cycle (Average Days) | 47.95 | 40.96 | 45.75 | 62.15 | 67.59 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 44.06 | 34.01 | 31.02 | 51.39 | 44.46 | |||||
Total Debt / Total Capital | 30.58 | 25.38 | 23.67 | 33.95 | 30.77 | |||||
LT Debt/Equity | 40.85 | 32.32 | 27.81 | 44.66 | 42.62 | |||||
Long-Term Debt / Total Capital | 28.36 | 24.11 | 21.22 | 29.5 | 29.5 | |||||
Total Liabilities / Total Assets | 51.81 | 49.86 | 47.56 | 53.76 | 51.69 | |||||
EBIT / Interest Expense | 12.76 | 22 | 15.11 | 14.44 | 7.85 | |||||
EBITDA / Interest Expense | 20.72 | 33.4 | 24.29 | 24.71 | 15.59 | |||||
(EBITDA - Capex) / Interest Expense | 14.67 | 25.73 | 17.18 | 16.71 | 9.05 | |||||
Total Debt / EBITDA | 1.06 | 0.58 | 0.74 | 1.22 | 1.22 | |||||
Net Debt / EBITDA | 0.99 | 0.52 | 0.65 | 1.21 | 1.18 | |||||
Total Debt / (EBITDA - Capex) | 1.49 | 0.75 | 1.04 | 1.8 | 2.1 | |||||
Net Debt / (EBITDA - Capex) | 1.4 | 0.67 | 0.92 | 1.79 | 2.03 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 77.93 | 40.73 | -14.97 | -0.87 | 8.71 | |||||
Gross Profit, 1 Yr. Growth % | 166.57 | 44.86 | -22.98 | -3.34 | 6.86 | |||||
EBITDA, 1 Yr. Growth % | 172.36 | 45.37 | -19.51 | -1.1 | -3.04 | |||||
EBITA, 1 Yr. Growth % | -4.49K | 55.39 | -28.07 | -6.45 | -15.52 | |||||
EBIT, 1 Yr. Growth % | -2.33K | 55.46 | -29.18 | -6.9 | -16.05 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -1.86K | 42.71 | -24.72 | -25.84 | 77.2 | |||||
Net Income, 1 Yr. Growth % | -1.86K | 42.71 | -24.72 | -25.84 | 77.2 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.11K | 45.37 | -25.16 | -20.83 | 2.11 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -1.85K | 47.37 | -21.53 | -23.8 | 81.05 | |||||
Accounts Receivable, 1 Yr. Growth % | 42.05 | 14.27 | -10.3 | 29.38 | -3.08 | |||||
Inventory, 1 Yr. Growth % | 46.04 | 17.25 | 12.07 | 37.32 | -6.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.47 | -2.32 | -0.42 | 13.31 | 7.71 | |||||
Total Assets, 1 Yr. Growth % | 1.85 | -0.68 | -0.25 | 12.38 | 7.58 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.1 | 3.33 | 4.34 | -0.91 | 12.41 | |||||
Common Equity, 1 Yr. Growth % | 14.1 | 3.33 | 4.34 | -0.91 | 12.41 | |||||
Cash From Operations, 1 Yr. Growth % | 207.13 | 33.93 | -36.3 | 8.36 | 12.85 | |||||
Capital Expenditures, 1 Yr. Growth % | 75.51 | 14.31 | -4.42 | 9.66 | 26.16 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 286.65 | 44.59 | -47.24 | 11.6 | -5.08 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 232.97 | 41.94 | -45.46 | 10.66 | -1.6 | |||||
Dividend Per Share, 1 Yr. Growth % | 17.51 | 55.19 | 19.35 | 15.54 | 9.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.64 | 58.24 | 9.39 | -8.19 | 3.81 | |||||
Gross Profit, 2 Yr. CAGR % | 17.06 | 96.51 | 5.62 | -13.72 | 1.63 | |||||
EBITDA, 2 Yr. CAGR % | 16 | 96.2 | 3.57 | -11.42 | -2.95 | |||||
EBITA, 2 Yr. CAGR % | 29.86 | 702.97 | 5.72 | -18.11 | -11.21 | |||||
EBIT, 2 Yr. CAGR % | 30.8 | 480.15 | 4.92 | -18.95 | -11.7 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.96 | 401.42 | 3.65 | -25.28 | 14.64 | |||||
Net Income, 2 Yr. CAGR % | 18.96 | 401.42 | 3.65 | -25.28 | 14.64 | |||||
Normalized Net Income, 2 Yr. CAGR % | 33.05 | 283.39 | 4.3 | -23.03 | -10.09 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 19.29 | 407.24 | 7.53 | -22.62 | 17.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.34 | 27.41 | 1.25 | 7.73 | 11.98 | |||||
Inventory, 2 Yr. CAGR % | 15.92 | 30.85 | 14.63 | 24.05 | 13.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.57 | -0.94 | -1.37 | 6.23 | 10.48 | |||||
Total Assets, 2 Yr. CAGR % | -0.94 | 0.57 | -0.46 | 5.88 | 9.95 | |||||
Tangible Book Value, 2 Yr. CAGR % | 2.75 | 8.58 | 3.83 | 1.68 | 5.54 | |||||
Common Equity, 2 Yr. CAGR % | 2.75 | 8.58 | 3.83 | 1.68 | 5.54 | |||||
Cash From Operations, 2 Yr. CAGR % | 28.06 | 102.82 | -7.63 | -16.91 | 10.58 | |||||
Capital Expenditures, 2 Yr. CAGR % | 11.59 | 41.64 | 4.53 | 2.38 | 17.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 47.38 | 136.85 | -18.23 | -23.37 | 2.78 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 41.73 | 117.7 | -17.46 | -22.42 | 4.22 | |||||
Dividend Per Share, 2 Yr. CAGR % | 15.4 | 35.04 | 36.1 | 17.43 | 12.71 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.65 | 22.75 | 28.65 | 5.86 | -2.87 | |||||
Gross Profit, 3 Yr. CAGR % | 16.26 | 25.68 | 43.81 | 2.55 | -7.34 | |||||
EBITDA, 3 Yr. CAGR % | 14.14 | 25.65 | 41.62 | 1.99 | -8.71 | |||||
EBITA, 3 Yr. CAGR % | 24.22 | 37.87 | 259.28 | 1.5 | -17.26 | |||||
EBIT, 3 Yr. CAGR % | 24.98 | 38.55 | 187.79 | 0.83 | -17.99 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 43.55 | 26.4 | 166.5 | -7.3 | -0.36 | |||||
Net Income, 3 Yr. CAGR % | 43.55 | 26.4 | 166.5 | -7.3 | -0.36 | |||||
Normalized Net Income, 3 Yr. CAGR % | 39.59 | 37.04 | 122.4 | -4.86 | -15.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 44.98 | 28 | 172.3 | -4.09 | 2.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 39.42 | 12.98 | 13.35 | 9.87 | 4 | |||||
Inventory, 3 Yr. CAGR % | 17.47 | 16.36 | 24.26 | 21.74 | 13.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.45 | -1.82 | -0.76 | 3.3 | 6.72 | |||||
Total Assets, 3 Yr. CAGR % | 2.32 | -0.85 | 0.3 | 3.65 | 6.44 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.93 | 2.95 | 7.15 | 2.23 | 5.14 | |||||
Common Equity, 3 Yr. CAGR % | 4.93 | 2.95 | 7.15 | 2.23 | 5.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.68 | 29.99 | 37.87 | -2.58 | -7.99 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.39 | 12.49 | 24.24 | 6.21 | 9.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 31.29 | 46.44 | 37.41 | -9.3 | -17.71 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 28.37 | 41.8 | 31.52 | -8.98 | -16.03 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.24 | 27.38 | 29.59 | 28.87 | 14.88 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 21.34 | 19.52 | 11.33 | 9.29 | 18.07 | |||||
Gross Profit, 5 Yr. CAGR % | 29.82 | 23.74 | 11.88 | 8.12 | 25.16 | |||||
EBITDA, 5 Yr. CAGR % | 32.51 | 23.69 | 10.1 | 7.68 | 22.19 | |||||
EBITA, 5 Yr. CAGR % | 53.27 | 42.64 | 16.46 | 12.01 | 105.5 | |||||
EBIT, 5 Yr. CAGR % | 49.14 | 44.01 | 16.53 | 11.89 | 79.49 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 106.52 | 35.47 | 26.01 | 2.43 | 90.17 | |||||
Net Income, 5 Yr. CAGR % | 106.52 | 35.47 | 26.01 | 2.43 | 90.17 | |||||
Normalized Net Income, 5 Yr. CAGR % | 41.47 | 40.63 | 24.23 | 8.8 | 54.81 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 102.44 | 36.22 | 28.65 | 4.66 | 94.58 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.75 | 8.2 | 22.67 | 10.85 | 12.8 | |||||
Inventory, 5 Yr. CAGR % | 17.57 | 15.21 | 16.32 | 19.38 | 19.85 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.65 | 0.21 | 0.31 | 1.32 | 3.59 | |||||
Total Assets, 5 Yr. CAGR % | 5.5 | 0.61 | 1.2 | 1.79 | 4.06 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.06 | 3.82 | 4.49 | 2.44 | 6.5 | |||||
Common Equity, 5 Yr. CAGR % | 7.06 | 3.82 | 4.49 | 2.44 | 6.5 | |||||
Cash From Operations, 5 Yr. CAGR % | 33.21 | 21.71 | 4.07 | 8.68 | 26.23 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.59 | 1.8 | 2.02 | 8.33 | 21.55 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 125.79 | 39.72 | 8.64 | 10.14 | 22.41 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 86.37 | 35.92 | 7.59 | 8.66 | 19.89 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.27 | 23.03 | 22.52 | 23.3 | 22.55 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















